BFM
REVBW icon

Boothbay Fund Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Boothbay Fund Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,135
Closed -$163K – 2159
2021
Q3 		$163K Sell
16,135
-216,227
-93% -$131K ﹤0.01% 1642
2021
Q2 		$2.33M Sell
232,362
-3,160
-1% -$1.88K 0.08% 321
2021
Q1 		$2.35M Sell
235,522
-296,784
-56% -$277K 0.09% 268
2020
Q4 		$5.35M Buy
+532,306
New +$363K 0.2% 91

Other funds holding REVBW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Boothbay Fund Management's REVBW Position: Q4 2021 in Review

Boothbay Fund Management sold out of Revelation Biosciences Warrant (REVBW) in Q4 2021, closing a stake of 16,135 shares — an estimated $163K sold.

Boothbay Fund Management first reported a position in REVBW in Q4 2020 and held it in 4 quarters. The position peaked at $5.35M in Q4 2020. 20 funds tracked by Wall St. Rank hold REVBW as of Q4 2021.

  • Boothbay Fund Management reported no remaining Revelation Biosciences Warrant position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 16,135 Revelation Biosciences Warrant shares in Q4 2021, an estimated $163K.
  • Boothbay Fund Management first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 4 quarters.
  • Boothbay Fund Management's Revelation Biosciences Warrant position peaked at $5.35M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.